tiprankstipranks
Ampio Pharmaceuticals (AMPE)
OTHER OTC:AMPE
US Market
Holding AMPE?
Track your performance easily

Ampio Pharmaceuticals (AMPE) Income Statement

511 Followers

Ampio Pharmaceuticals Income Statement

Last quarter (Q ), Ampio Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Ampio Pharmaceuticals's net income was $-2.05M. See Ampio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 5.17M$ 9.52M$ 20.38M$ 20.57M$ 15.83M$ -18.58M
Operating Income
$ -5.17M$ -9.52M$ -20.38M$ -20.57M$ -15.83M$ -18.58M
Net Non Operating Interest Income Expense
$ 245.00K$ 348.00K$ -220.00K$ 4.00K$ 12.00K$ 77.00K
Other Income Expense
$ -276.00K$ 538.00K$ 3.83M$ -3.49M$ 72.00K$ -4.87M
Pretax Income
$ -4.65M$ -8.63M$ -16.34M$ -17.07M$ -15.89M$ -13.63M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -8.63M$ -8.63M$ -16.34M$ -17.07M$ -15.89M$ -13.63M
Basic EPS
$ -10.66$ -10.66$ -21.60$ -27.00$ -27.00$ -30.00
Diluted EPS
$ -10.66$ -10.66$ -29.40$ -30.00$ -27.00$ -42.00
Basic Average Shares
$ 2.49M$ 810.11K$ 753.62K$ 664.33K$ 576.15K$ 435.34K
Diluted Average Shares
$ 2.49M$ 810.11K$ 753.62K$ 683.21K$ 576.15K$ 437.12K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.12M$ 9.52M$ 20.38M$ 20.57M$ 15.83M$ -18.58M
Net Income From Continuing And Discontinued Operation
$ -8.63M$ -8.63M$ -16.34M$ -17.07M$ -15.89M$ -13.63M
Normalized Income
$ -970.04K$ -7.05M----
Interest Expense
------
EBIT
$ -9.52M$ -9.52M$ -20.38M$ -20.57M$ -15.83M$ -13.63M
EBITDA
$ -9.40M$ -9.40M$ -19.33M$ -19.48M$ -14.66M$ -12.36M
Currency in USD

Ampio Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis